Acorda Therapeutics Inc
Change company Symbol lookup
Select an option...
ACOR Acorda Therapeutics Inc
BOSC BOS Better Online Solutions Ltd
BORR Borr Drilling Ltd
BOOT Boot Barn Holdings Inc
EPD Enterprise Products Partners LP
$JSEMET EMIX Smaller Europe Metal Production
CUB Cubic Corp
FB Facebook Inc
NWVCF Enwave Corp
MMM 3M Co
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Acorda Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. As of December 31, 2016, the Company marketed three United States Food and Drug Administration (FDA)-approved therapies, including Ampyra (dalfampridine) Extended Release Tablets, 10 milligram (mg), a treatment to improve walking in patients with multiple sclerosis (MS). The Company also markets Zanaflex Capsules and tablets, FDA-approved as short-acting drugs for the management of spasticity, and Qutenza, an FDA-approved dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia, also known as post-shingles pain. The Company has a pipeline of neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and MS. The Company's product candidate, CVT-301, is a self-administered inhaled formulation of levodopa.

Closing Price
$6.70
Day's Change
0.33 (5.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.72
Day's Low
6.08
Volume
(Light)
Volume:
1,466,973

10-day average volume:
3,845,951
1,466,973
  • Prev Close
    6.37
  • Today's Open
    6.24
  • Day's Range
    6.08-6.72
  • Avg Vol (10-day)
    3.8M
  • Last (time)
    4:00p ET 01/15/21
  • Last (size)
    64
  • 52-Wk Range
    2.53 - 15.30
    LowHigh
  • (01/23/20 - 09/14/20)
    164.36%
  • 111.9%
  • Market Cap
    63.5M
  • Shares Outstanding
    9.5M
  • 5.32
  • 0.80x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 41.36
  • (% of float 12/31/20)
    5.52

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.